| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-06 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.22 | 6e-06 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.12 | 3e-05 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.12 | 6e-05 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.14 | 8e-05 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |